Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages.

Wasinger C, Hofer A, Spadiut O, Hohenegger M.

Sci Rep. 2018 Apr 19;8(1):6245. doi: 10.1038/s41598-018-24709-0.

2.

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.

Taschner-Mandl S, Schwarz M, Blaha J, Kauer M, Kromp F, Frank N, Rifatbegovic F, Weiss T, Ladenstein R, Hohenegger M, Ambros IM, Ambros PF.

Oncotarget. 2016 Jan 19;7(3):3571-86. doi: 10.18632/oncotarget.6527.

3.

In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin.

Atil B, Berger-Sieczkowski E, Bardy J, Werner M, Hohenegger M.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Jan;389(1):17-32. doi: 10.1007/s00210-015-1169-3. Epub 2015 Aug 30.

4.

Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells.

Minichsdorfer C, Wasinger C, Sieczkowski E, Atil B, Hohenegger M.

Melanoma Res. 2015 Aug;25(4):284-94. doi: 10.1097/CMR.0000000000000172.

5.

Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells.

Wasinger C, Künzl M, Minichsdorfer C, Höller C, Zellner M, Hohenegger M.

Br J Pharmacol. 2014 Dec;171(24):5708-27. doi: 10.1111/bph.12871.

6.

Biodiversity of the Surface Microbial Consortia from Limburger, Reblochon, Livarot, Tilsit, and Gubbeen Cheeses.

Cogan TM, Goerges S, Gelsomino R, Larpin S, Hohenegger M, Bora N, Jamet E, Rea MC, Mounier J, Vancanneyt M, Guéguen M, Desmasures N, Swings J, Goodfellow M, Ward AC, Sebastiani H, Irlinger F, Chamba JF, Beduhn R, Scherer S.

Microbiol Spectr. 2014 Feb;2(1):CM-0010-2012. doi: 10.1128/microbiolspec.CM-0010-2012.

PMID:
26082119
7.

Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling and arrhythmias in the heart evoked by β-adrenergic stimulation.

Nebel M, Schwoerer AP, Warszta D, Siebrands CC, Limbrock AC, Swarbrick JM, Fliegert R, Weber K, Bruhn S, Hohenegger M, Geisler A, Herich L, Schlegel S, Carrier L, Eschenhagen T, Potter BV, Ehmke H, Guse AH.

J Biol Chem. 2013 May 31;288(22):16017-30. doi: 10.1074/jbc.M112.441246. Epub 2013 Apr 5.

8.

Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells.

Werner M, Atil B, Sieczkowski E, Chiba P, Hohenegger M.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Jul;386(7):605-17. doi: 10.1007/s00210-013-0859-y. Epub 2013 Apr 7.

9.

Cytoprotective effect of the small GTPase RhoB expressed upon treatment of fibroblasts with the Ras-glucosylating Clostridium sordellii lethal toxin.

Huelsenbeck J, May M, Schulz F, Schelle I, Ronkina N, Hohenegger M, Fritz G, Just I, Gerhard R, Genth H.

FEBS Lett. 2012 Oct 19;586(20):3665-73. doi: 10.1016/j.febslet.2012.08.024. Epub 2012 Sep 11.

10.

Drug induced rhabdomyolysis.

Hohenegger M.

Curr Opin Pharmacol. 2012 Jun;12(3):335-9. doi: 10.1016/j.coph.2012.04.002. Epub 2012 May 5. Review.

11.

Get the signal to reduce the noise of pharmacological 'toys'.

Hohenegger M.

Curr Opin Pharmacol. 2012 Jun;12(3):323-5. doi: 10.1016/j.coph.2012.03.005. Epub 2012 Apr 3. No abstract available.

PMID:
22480724
12.

Novel and current treatment concepts using pulmonary drug delivery.

Hohenegger M.

Curr Pharm Des. 2010;16(22):2484-92. Review.

PMID:
20509845
13.

Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells.

Sieczkowski E, Lehner C, Ambros PF, Hohenegger M.

Int J Cancer. 2010 May 1;126(9):2025-35. doi: 10.1002/ijc.24885.

14.

[Medical emergency management of acute aortic dissection--a case report: preventing patient stress].

Hohenegger M.

Pflege Z. 2009 Aug;62(8):470-1. German. No abstract available.

PMID:
19728438
15.

Autocrine amplification loop in statin-induced apoptosis of human melanoma cells.

Minichsdorfer C, Hohenegger M.

Br J Pharmacol. 2009 Aug;157(7):1278-90. doi: 10.1111/j.1476-5381.2009.00298.x. Epub 2009 Jun 25.

16.

[Procedures within the scope of emergency care: acute chest pain].

Hohenegger M.

Pflege Z. 2009 Jun;62(6):350-3. German. No abstract available.

PMID:
19555005
17.

NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist.

Dammermann W, Zhang B, Nebel M, Cordiglieri C, Odoardi F, Kirchberger T, Kawakami N, Dowden J, Schmid F, Dornmair K, Hohenegger M, Flügel A, Guse AH, Potter BV.

Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10678-83. doi: 10.1073/pnas.0809997106. Epub 2009 Jun 16.

18.

[Management of patients with Prinzmetal angina: rapid and effective management is critical].

Hohenegger M.

Pflege Z. 2009 Mar;62(3):154-6. German. No abstract available.

PMID:
19348404
19.

[Nursing the ventilated patient: a large measure of meticulous care needed].

Hohenegger M.

Pflege Z. 2008 Jun;61(6):310-2. German. No abstract available.

PMID:
18605610
20.

I like to move it, move it.

Hohenegger M.

Curr Opin Pharmacol. 2008 Jun;8(3):308-10. doi: 10.1016/j.coph.2008.04.004. Epub 2008 May 16. No abstract available.

PMID:
18487085
21.

[Acute bolus incident--protocol in resuscitation: setting the correct priorities].

Hohenegger M.

Pflege Z. 2006 Dec;59(12):752-3. German. No abstract available.

PMID:
17260552
22.

[Febrile convulsion as pediatric emergency: panic is the wrong way].

Hohenegger M.

Pflege Z. 2006 Jul;59(7):428-30. German. No abstract available.

PMID:
16883742
23.

[Hypovolemic shock and what nurses can do].

Hohenegger M.

Pflege Aktuell. 2006 Mar;60:140-4. German. No abstract available.

PMID:
16566350
24.

Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells.

May C, Weigl L, Karel A, Hohenegger M.

Biochem Pharmacol. 2006 May 14;71(10):1497-509. Epub 2006 Mar 14.

PMID:
16533496
25.

Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676.

Wolner I, Kassack MU, Ullmann H, Karel A, Hohenegger M.

Br J Pharmacol. 2005 Oct;146(4):525-33.

26.

Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells.

Sacher J, Weigl L, Werner M, Szegedi C, Hohenegger M.

J Pharmacol Exp Ther. 2005 Sep;314(3):1032-41. Epub 2005 May 24.

27.

[Medical emergency basic measures: every minute counts].

Hohenegger M.

Pflege Z. 2004 Dec;57(12):837-40. German. No abstract available.

PMID:
15646105
28.
29.

Covalent modification of G-proteins by affinity labeling.

Hohenegger M, Freissmuth M, Nanoff C.

Methods Mol Biol. 2004;259:183-95.

PMID:
15250493
30.

Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

Bacher I, Zidar A, Kratzel M, Hohenegger M.

Biochem J. 2004 Jul 1;381(Pt 1):147-54.

31.

No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes.

Deusch E, Kraft B, Nahlik G, Weigl L, Hohenegger M, Kress HG.

J Neuroimmunol. 2003 Aug;141(1-2):99-103.

PMID:
12965259
32.

[Cardiopulmonary resuscitation: better knowledge--less panic].

Hohenegger M.

Pflege Z. 2003 Mar;56(3):159-62. German. No abstract available.

PMID:
12696332
33.

Store operated Ca2+ influx by selective depletion of ryanodine sensitive Ca2+ pools in primary human skeletal muscle cells.

Weigl L, Zidar A, Gscheidlinger R, Karel A, Hohenegger M.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Apr;367(4):353-63. Epub 2003 Mar 6.

PMID:
12690427
34.

[Shock--4: Stabilizing hemodynamics with volume and catecholamines].

Hohenegger M.

Pflege Z. 2003 Feb;56(2):87-9. German. No abstract available.

PMID:
12673860
35.

[Shock--3: Forms of shock: etiology determines therapy].

Hohenegger M.

Pflege Z. 2003 Jan;56(1):9-10. German. No abstract available.

PMID:
12630202
36.

[Shock--2: Therapy of shock: Fluids are necessary].

Hohenegger M.

Pflege Z. 2002 Nov;55(11):771-3; quiz 774. German. No abstract available.

PMID:
12494685
37.

[Shock--I. Rapid intervention is life saving].

Hohenegger M.

Pflege Z. 2002 Oct;55(10):697-9. German. No abstract available.

PMID:
12432737
38.

[Proper help can save lives. Often symptoms are misinterpreted, nonetheless every second counts for the diabetic patient].

Hohenegger M.

Pflege Aktuell. 2002 Jul;56(7-8):413-5. German. No abstract available.

PMID:
12162001
39.

Nicotinic acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor.

Hohenegger M, Suko J, Gscheidlinger R, Drobny H, Zidar A.

Biochem J. 2002 Oct 15;367(Pt 2):423-31.

40.

Effects of indole on breathing in rats.

Hohenegger M, Frydrichová M, Hezinová A, Vízek M, Scheiber V.

Nephron. 2001 Jun;88(2):191-2. No abstract available.

PMID:
11399929
41.

Suramin and the suramin analogue NF307 discriminate among calmodulin-binding sites.

Klinger M, Bofill-Cardona E, Mayer B, Nanoff C, Freissmuth M, Hohenegger M.

Biochem J. 2001 May 1;355(Pt 3):827-33.

42.

Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet.

Kudlacek O, Mitterauer T, Nanoff C, Hohenegger M, Tang WJ, Freissmuth M, Kleuss C.

J Biol Chem. 2001 Feb 2;276(5):3010-6. Epub 2000 Oct 24.

43.
44.

Lipoprotein(a) in homozygous familial hypercholesterolemia.

Kraft HG, Lingenhel A, Raal FJ, Hohenegger M, Utermann G.

Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):522-8.

45.

Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytes.

Hohenegger M, Berg I, Weigl L, Mayr GW, Potter BV, Guse AH.

Br J Pharmacol. 1999 Nov;128(6):1235-40.

46.

Metal-dependent nucleotide binding to the Escherichia coli rotamase SlyD.

Mitterauer T, Nanoff C, Ahorn H, Freissmuth M, Hohenegger M.

Biochem J. 1999 Aug 15;342 ( Pt 1):33-9.

47.

Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.

Kerschdorfer L, König P, Neyer U, Bösmüller C, Lhotta K, Auinger M, Hohenegger M, Riegler P, Margreiter R, Utermann G, Dieplinger H, Kronenberg F.

Atherosclerosis. 1999 Jun;144(2):381-91.

PMID:
10407499
48.

Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose.

Guse AH, da Silva CP, Berg I, Skapenko AL, Weber K, Heyer P, Hohenegger M, Ashamu GA, Schulze-Koops H, Potter BV, Mayr GW.

Nature. 1999 Mar 4;398(6722):70-3.

PMID:
10078531
49.

Suramin and suramin analogs activate skeletal muscle ryanodine receptor via a calmodulin binding site.

Klinger M, Freissmuth M, Nickel P, Stäbler-Schwarzbart M, Kassack M, Suko J, Hohenegger M.

Mol Pharmacol. 1999 Mar;55(3):462-72.

50.

The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.

Mitterauer T, Hohenegger M, Tang WJ, Nanoff C, Freissmuth M.

Biochemistry. 1998 Nov 17;37(46):16183-91.

PMID:
9819210

Supplemental Content

Loading ...
Support Center